The most critical interaction in a community pharmacy often happens in a few rushed seconds. A customer presents a symptom, or asks for advice on a medication, and the attendant behind the counter must respond, balancing technical knowledge, regulatory guidance, and sales acumen on the fly. It’s a moment ripe for human error, inconsistency, and missed opportunity, a gap that Brazilian startup Maggu AI is betting a real-time AI copilot can fill.
Founded in 2024 and based in São Paulo, Maggu has built an AI assistant designed to integrate directly into a pharmacy’s existing point-of-sale or enterprise resource planning system. The tool surfaces drug information, package inserts, and product suggestions in real time to guide the attendant through the consultation. In March 2026, the company closed a seed round of approximately $4 million, led by DGF Investments, to scale its reach across Brazil’s pharmaceutical retail sector [Preqin, March 2026] [StartupResearcher, March 2026].
The wedge: decision support at the point of care
Maggu’s product is not a back-office analytics dashboard. Its differentiation is its positioning as a counter-facing copilot, acting as a live decision-support and training layer during the customer interaction itself [Perplexity Sonar Pro Brief]. The company emphasizes a plug-and-play integration into incumbent pharmacy ERP systems, a practical choice meant to minimize implementation friction in a sector not known for rapid IT overhauls.
The copilot’s claimed knowledge base covers approximately 1.6 million products nationwide, giving attendants instant access to technical data that might otherwise require a manual lookup or fall outside their personal expertise [Perplexity Sonar Pro Brief]. The pitch to pharmacy chains hinges on improved outcomes: more consistent technical guidance, higher average transaction values, faster onboarding for new staff, and ultimately, stronger customer loyalty.
Traction and the Brazilian context
Early signals suggest the concept is finding a market. The company reported a twentyfold increase in its client base over the year leading up to March 2026 [StartupResearcher, March 2026]. While specific customer names are not public, the growth metric points to initial product-market fit within Brazil’s fragmented but vast pharmacy retail landscape.
The team and the seed capital
Maggu was founded by a group of five co-founders: Felipe Trevisan, Pedro Magela, Reslley Gabriel, Luiz Andrade, and Rérica Lins Ghirelli [Preqin, 2026]. Public profiles list Trevisan as CEO, Magela as COO, and Gabriel as Chief Data and AI Officer [Perplexity Sonar Pro Brief]. The $4 million seed round, which valued the company at $26 million according to one report, attracted a mix of local and regional investors including DGF Investments, IC Ventures, Norte Ventures, and Latitud [StartupResearcher, March 2026] [LatamRepublic, 2026].
An honest counterfactual
For all its early momentum, Maggu’s path is not without credible hurdles. The company operates in a space where regulatory scrutiny is high and the margin for error in medical advice is zero. While the tool provides information, the ultimate responsibility for patient care rests with the pharmacist or attendant, a dynamic that requires careful product design and clear disclaimers.
Furthermore, the competitive landscape, while not yet populated with named direct rivals in the sources, is inherently attractive. Larger healthcare IT vendors or pharmacy software incumbents could develop similar in-house capabilities. Maggu’s answer likely rests in its focused execution, its first-mover data advantage in the Brazilian market, and the depth of its product integration, which aims to become indispensable to the daily workflow.
What to watch next
The fresh capital gives Maggu a clear runway for expansion. Key milestones to monitor will be the announcement of flagship pharmacy chain partnerships, any moves into adjacent Latin American markets, and enhancements to the copilot’s capabilities, perhaps venturing into chronic disease management support or tighter integration with prescription workflows.